Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolyon Jesty

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 5, 2008
Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: a dilemma in harm reductionGaurav Girdhar, Sulan Xu, Danny Bluestein, et al.
The Journal of Biological Chemistry|March 18, 2004
A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1Wadie F Bahou, Lesley Scudder, David Rubenstein, et al.
Pathophysiology of Haemostasis and Thrombosis|June 15, 2006
The extent of platelet activation under shear depends on platelet count: differential expression of anionic phospholipid and factor VaKatherine Schulz-Heik, Jaimohan Ramachandran, Danny Bluestein, et al.
Annals of Biomedical Engineering|September 28, 2004
Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valvesWei Yin, Yared Alemu, Klaus Affeld, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assaysMaria T Grosse Perdekamp, David A Rubenstein, Jolyon Jesty, et al.
Circulation|October 31, 2002
Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potentialSergey V Brodsky, Kazimierz Malinowski, Marc Golightly, et al.
Advances in Experimental Medicine and Biology|August 9, 2006
gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammationBerhane Ghebrehiwet, Claudia CebadaMora, Lee Tantral, et al.
Journal of Biomechanics|May 21, 2010
Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designsMichalis Xenos, Gaurav Girdhar, Yared Alemu, et al.
Artificial Organs|September 28, 2005
Flow-induced platelet activation in a St. Jude mechanical heart valve, a trileaflet polymeric heart valve, and a St. Jude tissue valveWei Yin, Siobhain Gallocher, Leonard Pinchuk, et al.
Journal of Thrombosis and Thrombolysis|September 18, 2013
Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist deviceJawaad Sheriff, Gaurav Girdhar, Wei-Che Chiu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 5, 2008
Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: a dilemma in harm reductionGaurav Girdhar, Sulan Xu, Danny Bluestein, et al.
The Journal of Biological Chemistry|March 18, 2004
A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1Wadie F Bahou, Lesley Scudder, David Rubenstein, et al.
Pathophysiology of Haemostasis and Thrombosis|June 15, 2006
The extent of platelet activation under shear depends on platelet count: differential expression of anionic phospholipid and factor VaKatherine Schulz-Heik, Jaimohan Ramachandran, Danny Bluestein, et al.
Annals of Biomedical Engineering|September 28, 2004
Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valvesWei Yin, Yared Alemu, Klaus Affeld, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assaysMaria T Grosse Perdekamp, David A Rubenstein, Jolyon Jesty, et al.
Circulation|October 31, 2002
Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potentialSergey V Brodsky, Kazimierz Malinowski, Marc Golightly, et al.
Advances in Experimental Medicine and Biology|August 9, 2006
gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammationBerhane Ghebrehiwet, Claudia CebadaMora, Lee Tantral, et al.
Journal of Biomechanics|May 21, 2010
Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designsMichalis Xenos, Gaurav Girdhar, Yared Alemu, et al.
Artificial Organs|September 28, 2005
Flow-induced platelet activation in a St. Jude mechanical heart valve, a trileaflet polymeric heart valve, and a St. Jude tissue valveWei Yin, Siobhain Gallocher, Leonard Pinchuk, et al.
Journal of Thrombosis and Thrombolysis|September 18, 2013
Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist deviceJawaad Sheriff, Gaurav Girdhar, Wei-Che Chiu, et al.
Pageof 4